4D Molecular Therapeutics | 10-Q: Q3 2024 Earnings Report
4D Molecular Therapeutics | 8-K: 4DMT Reports Third Quarter 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones
4D Molecular Therapeutics | 10-Q: Q2 2024 Earnings Report
4D Molecular Therapeutics | 8-K: 4DMT Reports Second Quarter 2024 Financial Results and Operational Highlights
4D Molecular Therapeutics | 8-K: 4DMT Reports First Quarter 2024 Financial Results and Operational Highlights
4D Molecular Therapeutics | 10-Q: Q1 2024 Earnings Report
4D Molecular Therapeutics | 10-K: FY2023 Annual Report
4D Molecular Therapeutics | 8-K: 4DMT Reports Third Quarter 2023 Financial Results and Operational Highlights
4D Molecular Therapeutics | 10-Q: Q3 2023 Earnings Report
4D Molecular Therapeutics | 10-Q: Q2 2023 Earnings Report
4D Molecular Therapeutics | 8-K: 4D Molecular Therapeutics Reports Second Quarter 2023 Financial Results and Operational Highlights
4D Molecular Therapeutics | 10-Q: Q1 2023 Earnings Report
4D Molecular Therapeutics | 8-K: 4D Molecular Therapeutics Reports First Quarter 2023 Financial Results and Operational Highlights
4D Molecular Therapeutics | 10-K: FY2022 Annual Report
4D Molecular Therapeutics | 8-K: 4D Molecular Therapeutics Reports Third Quarter 2022 Financial Results
4D Molecular Therapeutics | 10-Q: Q3 2022 Earnings Report
4D Molecular Therapeutics | 8-K: 4D Molecular Therapeutics Reports Second Quarter 2022 Financial Results and Provides 4D-310 Program Update
4D Molecular Therapeutics | 10-Q: Q2 2022 Earnings Report
4D Molecular Therapeutics | 8-K: 4D Molecular Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Updates
4D Molecular Therapeutics | 10-Q: Q1 2022 Earnings Report
No Data